[[abstract]]Cholesterol‐α‐glucosyltransferase (CGT) encoded by the type 1 capsular polysaccharide biosynthesis protein J (capJ) gene of Helicobacter pylori converts cellular cholesterol into cholesteryl glucosides. H. pylori infection induces autophagy that may increase bacterial survival in epithelial cells. However, the role of H. pylori CGT that exploits lipid rafts in interfering with autophagy for bacterial survival in macrophages has not been investigated. Here, we show that wild‐type H. pylori carrying CGT modulates cholesterol to trigger autophagy and restrain autophagosome fusion with lysosomes, permitting a significantly higher bacterial burden in macrophages than that in a capJ‐knockout (∆CapJ) mutant. Knockdown of autophagy‐rela...
Helicobacter pylori infects approximately half of the human population and is the main cause of vari...
Helicobacter pylori, a Gram negative bacterium that has colonized humans for millennia, has develope...
Helicobacter pylori-derived CagA, a type IV secretion system effector, plays a role as an oncogenic ...
[[abstract]]Cholesterol-α-glucosyltransferase (CGT) encoded by the type 1 capsular polysaccharide bi...
Background/PurposeHelicobacter pylori colonizes the human stomach and contributes to chronic inflamm...
Helicobacter pylori infection is associated with several gastrointestinal diseases, including gastri...
Helicobacter pylori is a Gram-negative bacterium that causes gastritis, gastric ulcers and stomach c...
Infection with Helicobacter pylori cag pathogenicity island (cagPAI)-positive strains is associated ...
Background and Aims Despite inducing an inflammatory response, Helicobacter pylori can persist in th...
Modification of bacterial surface structures, such as the lipid A portion of lipopolysaccharide (LPS...
ABSTRACT Infection of the human stomach caused by Helicobacter pylori is very common, as the pathoge...
Helicobacter pylori causes gastritis, which has been attributed to the development of H. pylori-spec...
Helicobacter pylori, the most common etiologic agent of gastric diseases including gastric cancer, i...
Helicobacter pylori is a gram-negative pathogen that infects 50% of the population worldwide and is ...
Abstract Background Helicobacter pylori specifically takes up cholesterol and incorporates it into t...
Helicobacter pylori infects approximately half of the human population and is the main cause of vari...
Helicobacter pylori, a Gram negative bacterium that has colonized humans for millennia, has develope...
Helicobacter pylori-derived CagA, a type IV secretion system effector, plays a role as an oncogenic ...
[[abstract]]Cholesterol-α-glucosyltransferase (CGT) encoded by the type 1 capsular polysaccharide bi...
Background/PurposeHelicobacter pylori colonizes the human stomach and contributes to chronic inflamm...
Helicobacter pylori infection is associated with several gastrointestinal diseases, including gastri...
Helicobacter pylori is a Gram-negative bacterium that causes gastritis, gastric ulcers and stomach c...
Infection with Helicobacter pylori cag pathogenicity island (cagPAI)-positive strains is associated ...
Background and Aims Despite inducing an inflammatory response, Helicobacter pylori can persist in th...
Modification of bacterial surface structures, such as the lipid A portion of lipopolysaccharide (LPS...
ABSTRACT Infection of the human stomach caused by Helicobacter pylori is very common, as the pathoge...
Helicobacter pylori causes gastritis, which has been attributed to the development of H. pylori-spec...
Helicobacter pylori, the most common etiologic agent of gastric diseases including gastric cancer, i...
Helicobacter pylori is a gram-negative pathogen that infects 50% of the population worldwide and is ...
Abstract Background Helicobacter pylori specifically takes up cholesterol and incorporates it into t...
Helicobacter pylori infects approximately half of the human population and is the main cause of vari...
Helicobacter pylori, a Gram negative bacterium that has colonized humans for millennia, has develope...
Helicobacter pylori-derived CagA, a type IV secretion system effector, plays a role as an oncogenic ...